Registry of Lobbyists
| Corporation: | GlaxoSmithKline |
| Associated registration: | 953603-5088-57 |
| Communication date: | 2023-08-24 |
| Posted date: | 2023-09-15 |
| Designated Public Office Holders who participated in the communication: |
Eric Bourbonnais,
Director, Investment Opportunities
Strategic Innovation Fund, Innovation, Science and Economic Development Canada (ISED) Celine Menard, Director General Financial Analysis and Oversight Branch, Innovation, Science and Economic Development Canada (ISED) Jocelyn Milburn, Director, Office of Life Sciences and Biomanufacturing Readiness Innovation, Science and Economic Development Canada (ISED) |
| Subject Matter of the communication: | Economic Development, Health |
| Responsible Officer who filed this communication report: | Sridhar Venkatesh |
| As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed. | |